PF-00915275

PF-00915275 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-00915275, covering 2008-09-29 to 2008-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks [Phase 2]